Cargando…

Drug Delivery Systems for Imaging and Therapy of Parkinson's Disease

Background: Although a variety of therapeutic approaches are available for the treatment of Parkinson’s disease, challenges limit effective therapy. Among these challenges are delivery of drugs through the blood brain barier to the target brain tissue and the side effects observed during long term a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gunay, Mine Silindir, Ozer, A. Yekta, Chalon, Sylvie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876593/ https://www.ncbi.nlm.nih.gov/pubmed/26714584 http://dx.doi.org/10.2174/1570159X14666151230124904

Ejemplares similares

(99m)Tc-radiolabeled Levofloxacin and micelles as infection and inflammation imaging agents
por: Silindir-Gunay, Mine, et al.
Publicado: (2020)

Neuroprotective and anti-inflammatory effects of a therapy combining agonists of nicotinic α7 and σ1 receptors in a rat model of Parkinson’s disease
por: Vetel, Steven, et al.
Publicado: (2020)

Challenges and trends in apomorphine drug delivery systems for the treatment of Parkinson's disease
por: Borkar, Nrupa, et al.
Publicado: (2018)

Growth Factor Therapy for Parkinson’s Disease: Alternative Delivery Systems
por: Jarrin, Sarah, et al.
Publicado: (2021)

Nanomedicine in the Face of Parkinson’s Disease: From Drug Delivery Systems to Nanozymes
por: Padilla-Godínez, Francisco J., et al.
Publicado: (2022)

The Management of Parkinson’s Disease: An Overview of the Current Advancements in Drug Delivery Systems
por: Nakmode, Deepa D., et al.
Publicado: (2023)

Non-oral continuous drug delivery based therapies and sleep dysfunction in Parkinson’s disease
por: Tall, P., et al.
Publicado: (2023)

Nanotechnology-based drug delivery of ropinirole for Parkinson’s disease
por: Barcia, Emilia, et al.
Publicado: (2017)

Effects of Zeolite as a Drug Delivery System on Cancer Therapy: A Systematic Review
por: Hao, Jessica, et al.
Publicado: (2021)

Real-World Longitudinal Experience of Botulinum Toxin Therapy for Parkinson and Essential Tremor
por: Samotus, Olivia, et al.
Publicado: (2022)

Drug therapy in patients with Parkinson’s disease
por: Müller, Thomas
Publicado: (2012)

Assessment of the Protection of Dopaminergic Neurons by an α7 Nicotinic Receptor Agonist, PHA 543613 Using [(18)F]LBT-999 in a Parkinson’s Disease Rat Model
por: Sérrière, Sophie, et al.
Publicado: (2015)

Preparation and evaluation of injectable Rasagiline mesylate dual-controlled drug delivery system for the treatment of Parkinson’s disease
por: Jiang, Ying, et al.
Publicado: (2017)

Recent Advances in Drug Therapy for Parkinson's Disease
por: Murakami, Hidetomo, et al.
Publicado: (2022)

Motor and nonmotor complications in Parkinson’s disease: an argument for continuous drug delivery?
por: Chaudhuri, K. Ray, et al.
Publicado: (2013)

Continuous Drug Delivery Aiming Continuous Dopaminergic Stimulation in Parkinson’s Disease
por: van Wamelen, Daniel J., et al.
Publicado: (2018)

Multifunctional magnetoliposomes as drug delivery vehicles for the potential treatment of Parkinson’s disease
por: Cifuentes, Javier, et al.
Publicado: (2023)

Nanoparticle drug delivery systems for synergistic delivery of tumor therapy
por: Chen, Daoyuan, et al.
Publicado: (2023)

Molecular Imaging of the GABAergic System in Parkinson’s Disease and Atypical Parkinsonisms
por: Terkelsen, Miriam H., et al.
Publicado: (2022)

Data-driven evolution of neurosurgical gene therapy delivery in Parkinson’s disease
por: Richardson, R Mark, et al.
Publicado: (2020)

Translational molecular imaging and drug development in Parkinson’s disease
por: Haider, Ahmed, et al.
Publicado: (2023)

Applications and developments of gene therapy drug delivery systems for genetic diseases
por: Pan, Xiuhua, et al.
Publicado: (2021)

Recent Advances in Drug Delivery System Fabricated by Microfluidics for Disease Therapy
por: Jia, Fuhao, et al.
Publicado: (2022)

Progress in drug delivery system for fibrosis therapy
por: Xing, Lei, et al.
Publicado: (2021)

Targeted Drug Delivery Systems Mediated by a Novel Peptide in Breast Cancer Therapy and Imaging
por: Lu, Ruei-Min, et al.
Publicado: (2013)

The functions and applications of A7R in anti-angiogenic therapy, imaging and drug delivery systems
por: Lu, Lu, et al.
Publicado: (2019)

Drug delivery systems as immunomodulators for therapy of infectious disease: Relevance to COVID-19()
por: Brain, Danielle, et al.
Publicado: (2021)

Constructive strategies for drug delivery systems in antivirus disease therapy by biosafety materials
por: Wang, Li, et al.
Publicado: (2022)

Improved Delivery Methods for Gene Therapy and Cell Transplantation in Parkinson’s Disease
por: Larson, Paul S.
Publicado: (2021)

Nanoparticle-based drug delivery systems for cancer therapy
por: Dang, Yu, et al.
Publicado: (2020)

Dual Modal Imaging-Guided Drug Delivery System for Combined Chemo-Photothermal Melanoma Therapy
por: Zhang, Dong, et al.
Publicado: (2021)

Alteration of the Oligodendrocyte Lineage Varies According to the Systemic Inflammatory Stimulus in Animal Models That Mimic the Encephalopathy of Prematurity
por: Favrais, Geraldine, et al.
Publicado: (2022)

Strategies for Image-Guided Therapy, Surgery, and Drug Delivery Using Photoacoustic Imaging
por: Moore, Colman, et al.
Publicado: (2019)

Drug reprofiling history and potential therapies against Parkinson’s disease
por: Latif, Komal, et al.
Publicado: (2022)

Drug Delivery Systems for Vitamin D Supplementation and Therapy
por: Glowka, Eliza, et al.
Publicado: (2019)

Polymeric Nanocarriers of Drug Delivery Systems in Cancer Therapy
por: Avramović, Nataša, et al.
Publicado: (2020)

Nanoparticles as Drug Delivery Systems of RNAi in Cancer Therapy
por: Li, Diedie, et al.
Publicado: (2021)

A Review on Drug Delivery System for Tumor Therapy
por: Liu, Guoxiang, et al.
Publicado: (2021)

Smart drug delivery systems for precise cancer therapy
por: Wang, Xiaoyou, et al.
Publicado: (2022)

Drug delivery systems for oral disease applications
por: Zhang, Yue, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c9qo283v3bt2qle5n5phu9miuk